Department of Research and Innovation
Current internal research studies
- Currently there is no Active Research Study
Current internal research studies
Research proposals involving human participants must be reviewed and approved by a Human Research Ethics Committee (HREC) before the research can commence. The HREC is established by and advises an institution or organisation, in this case CDD, regarding ethical approval for research projects.
“To protect the welfare and rights of the participants in research and the primary responsibility of each member is to decide, independently, whether in his or her opinion, the conduct of each research proposal submitted to the HREC will protect participants.” (NHMRC – National Statement on Ethical Conduct in Research Involving Humans), whilst considering the principles of ethical conduct:
Therefore,
The members of a HREC must be representative of the community. As such, a minimum composition is required:
If you wish to make a complaint regarding the ethical conduct of the staff, please email research@cdd.com.au.
A clinical trial falls into one of four phases:
Phase One Trials:
Phase Two Trials:
Phase Three Trials:
Phase Four Trials:
Who runs a Clinical Trial?
Who can participate in a Clinical Trial?
For every clinical trial, there are a set of guidelines which specify who can participate in the trial. These include:
These guidelines are set in place in order to minimize any study associated risks to the patient.
If you are found ineligible for a study – it is for your own safety!
There are many benefits to be gained from participating in a clinical trial. For patients these include:
In addition to the benefits available from participating in a clinical trial, there are also risks associated with being a participant in a study. These include:
Finally, the patient also has responsibilities when participating in a clinical trial. For example, committing to regular clinic visits or having to maintain a diary of your condition.
Research terms that are often used when describing a clinical trial include:
Adverse Events: Undesirable side effects that may occur in a clinical trial, which may or may not be a result of taking a study medicine.
Audits: Throughout the duration of a clinical trial and after the trial has been completed, audits may be conducted. These routine checks are performed to ensure that the trial is conducted responsibly and ethically.
Informed Consent: Participants must give fully informed voluntary written consent before they are able to take part in a study. Before enrolling in a trial, participants discuss the study with the doctor. This consent form indicates that participants are fully informed and are taking part in the study of their own free will.
Placebo: A placebo is an inactive substance that may be given to the control group of patients in a study. This substance looks like a medicine but does not contain any medicine.
Protocol: A Clinical Trial Protocol is a detailed description of the design and procedures of a research study. The protocol provides information on what is being researched, why it is being researched, how the research will be conducted and when the research will begin and end.
TGA (Therapeutic Goods Administration): The TGA is an Australian organisation that regulates the testing, manufacture and use of medicines and devices. Medicines and medical devices must be approved by the TGA before they can be made available commercially to the public.
Factors Effecting the Validity of a Clinical Trial
Many factors can influence the effectiveness of a clinical trial and whether the results of the trial are valid. These can include:
Blinding: Blinding minimises the chance of biased reporting when participants or doctors discuss the effects of the treatment. Double-blind procedures lead to a more effective study.
Single-blind studies: In single blind studies the participant is unaware of which treatment they are receiving but the doctors and researchers are aware of the treatment that the patient is receiving.
Double-blind studies: In double-blind studies both the doctor and the participant are unaware of which of the listed study treatments the participant is receiving.
Control Groups: In clinical trials, there are usually at least two groups. One is an experimental group which is given the new treatment being studied. The other is a control group which is given a standard treatment currently available on the market. If standard treatment is unavailable, the control group is given a placebo (a look-alike pill with no active medicine). Control groups help ensure that the outcomes of the new treatment are not biased by patients’ beliefs.
Randomisation: Randomised trials are clinical trials where participants are assigned to a treatment group on a random basis. This means that patients are assigned to groups irrespective of their age, gender, medical condition or any other similar factors. These sorts of trials are more reliable.
Sample size: Sample size refers to the number of patients involved in the study. Usually, the more people involved in a trial, the more reliable the results of the study will be.